Xceleron is moving to a new custom-built facility in Germantown, MD, which is expected to be fully operational by March 31. The move follows a $2.4 million investment from Albion Ventures and Solon Ventures. The company is relocating senior analytical staff to Germantown from York, and hiring new staff in Maryland. Xceleron will retain a study design and project management presence in the UK. The facility is capable of providing a range of studies including absolute bioavailability, metabolism ...